ARCUTIS BIOTHERAPEUTIC
10.15
20-سبتمبر-24 14:59:59
15 متأخرة بدقائق
الأسهم
+0.01
+0.10%
نطاق اليوم
9.78 - 10.31
ISIN
N/A
المصدر
NASDAQ
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 مايو 2024 15:00:00 بحسب Nasdaq GlobeNewswire
-
Arcutis to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
29 أبريل 2024 15:00:00 بحسب Nasdaq GlobeNewswire
-
Arcutis Appoints David Topper as Chief Financial Officer
10 أبريل 2024 07:00:00 بحسب Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 أبريل 2024 15:00:00 بحسب Nasdaq GlobeNewswire
-
Arcutis to Present at the 23rd Annual Needham Virtual Healthcare Conference
28 مارس 2024 07:00:00 بحسب Nasdaq GlobeNewswire
-
Arcutis Promotes Todd Tucker to Chief Human Resources Officer
11 مارس 2024 07:00:00 بحسب Nasdaq GlobeNewswire
-
09 مارس 2024 15:00:00 بحسب Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 مارس 2024 15:00:00 بحسب Nasdaq GlobeNewswire
-
04 مارس 2024 15:00:00 بحسب Nasdaq GlobeNewswire
-
04 مارس 2024 07:00:00 بحسب Nasdaq GlobeNewswire
-
Arcutis to Present at the TD Cowen 44th Annual Health Care Conference
29 فبراير 2024 16:00:33 بحسب Nasdaq GlobeNewswire
-
Arcutis Announces Pricing of $150 Million Public Offering
28 فبراير 2024 22:30:21 بحسب Nasdaq GlobeNewswire
-
Arcutis Announces Proposed Public Offering
28 فبراير 2024 15:10:00 بحسب Nasdaq GlobeNewswire
-
28 فبراير 2024 15:00:00 بحسب Nasdaq GlobeNewswire
-
Arcutis Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
27 فبراير 2024 04:50:12 بحسب Nasdaq GlobeNewswire
-
Arcutis to Report Fourth Quarter and Full Year 2023 Financial Results
16 فبراير 2024 07:00:00 بحسب Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 فبراير 2024 15:00:00 بحسب Nasdaq GlobeNewswire
-
Arcutis to Present at the Guggenheim Healthcare Talks – 6th Annual Biotechnology Conference
31 يناير 2024 07:00:00 بحسب Nasdaq GlobeNewswire